IP Verse

Senju Pharmaceutical competitive analysis

Explore the latest publications and patents granted to Senju Pharmaceutical, showcasing their recent innovations and technological advancements.

Last updated on: Sep 23, 2025

Publication Number	Publication Date	Title	Legal Status
Get instant update for new patents of Senju Pharmaceutical
EP2977044	Jan 31, 2018	Two-Layer Separation-Type Eye Drop Containing Squalane	No Opposition Filed Within Time Limit

Discover the latest PTAB cases involving Senju Pharmaceutical, highlighting their recent legal challenges and patent disputes.

Last updated on: Sep 29, 2025

Proceeding Number	Filing Date	Petitioner	Respondent	Status
Get alerts for PTAB Cases involving Senju Pharmaceutical
IPR2016-01163	Jun 8, 2016	MYLAN PHARMACEUTICALS	SENJU PHARMACEUTICALS	Terminated-Settled
IPR2016-00626	Feb 25, 2016	MYLAN PHARMACEUTICALS	SENJU PHARMACEUTICAL	Terminated-Settled
IPR2016-00091	Nov 2, 2015	INNOPHARMA LICENSING	SENJU PHARMACEUTICAL	Final Written Decision
IPR2016-00090	Nov 2, 2015	INNOPHARMA LICENSING	SENJU PHARMACEUTICAL	Final Written Decision
IPR2016-00089	Nov 2, 2015	INNOPHARMA LICENSING	SENJU PHARMACEUTICAL	Final Written Decision
IPR2015-01871	Sep 4, 2015	LUPIN	SENJU PHARMACEUTICAL	Final Written Decision
IPR2015-01205	May 15, 2015	AKORN	SENJU PHARMACEUTICAL	Final Written Decision
IPR2015-01105	Apr 23, 2015	LUPIN	SENJU PHARMACEUTICAL	Final Written Decision
IPR2015-01100	Apr 23, 2015	LUPIN	SENJU PHARMACEUTICAL	Final Written Decision
IPR2015-01099	Apr 23, 2015	LUPIN	SENJU PHARMACEUTICAL	Final Written Decision

IP litigation analysis comparing Senju Pharmaceutical with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 25, 2025

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced	Strategy Type
SENJU PHARMACEUTICAL	-	-	-	14	Non-Active
INNOPHARMA LICENSING	-	-	7	-	Highly Aggressive
LUPIN	-	1	15	-	Highly Aggressive
METRICS	-	-	2	-	Highly Aggressive